Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
Authors:
Open Access
- 26 August 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (16) , 20684-20697
Abstract
The tumor immune microenvironment of lung cancer is associated with prognosis and immunotherapy efficacy. Long noncoding RNAs are identified as prognostic biomarkers associated with immune functions. We constructed a signature comprising differentially expressed immune-related lncRNAs to predict the prognosis of patients with lung adenocarcinoma. We established the immune-related lncRNA signature by pairing immune-related lncRNAs regardless of expression level and lung adenocarcinoma patients were divided into high- and low-risk groups. The prognosis of patients in the two groups was significantly different; The immune-related lncRNA signature could serve as an independent lung adenocarcinoma prognostic indicator. The signature correlated negatively with B cell, CD4+ T cell, M2 macrophage, neutrophil, and monocyte immune infiltration. Patients with low risk scores had a higher abundance of immune cells and stromal cells around the tumor. Gene set enrichment analysis showed that samples from low-risk group were more active in the IgA production in intestinal immune network and the T and B cell receptor signaling pathway. High-risk groups had significant involvement of the cell cycle, DNA replication, adherens junction, actin cytoskeleton regulation, pathways in cancer, and TGF-β signaling pathways. High risk scores correlated significantly negatively with high CTLA-4 and HAVCR2 expression and higher median inhibitory concentration of common anti-tumor chemotherapeutics (e.g., cisplatin, paclitaxel, gemcitabine) and targeted therapy (e.g., erlotinib and gefitinib). We identified a reliable immune-related lncRNA lung adenocarcinoma prognosis model, and the immune-related lncRNA signature showed promising clinical prediction value.Keywords
This publication has 33 references indexed in Scilit:
- Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancerJournal for ImmunoTherapy of Cancer, 2020
- A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasisGenome Research, 2019
- Landscape of cancer diagnostic biomarkers from specifically expressed genesBriefings in Bioinformatics, 2019
- La myocardite : une toxicité rare mais grave sous immunothérapieBulletin du Cancer, 2019
- Lung CancerMedical Clinics of North America, 2019
- Systematic identification of lincRNA‐based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinomaInternational Journal of Cancer, 2018
- A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancerAging, 2018
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer PatientsClinical Cancer Research, 2012
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005